Literature DB >> 21689621

Locoregional therapy for hepatocellular carcinoma.

Marcelo Guimaraes1, Renan Uflacker.   

Abstract

Locoregional therapies for hepatocellular carcinoma have progressed greatly in the last 30 years, beginning with the introduction of chemoembolization. Embolization techniques have evolved with the use of drug-eluting beads and radioembolization with yttrium-90. In the last 10 years, several new ablation techniques were developed including radiofrequency ablation, microwave ablation, cryoablation, laser ablation, and irreversible electroporation. Isolated or in combination, these techniques have already shown that they can improve patient survival and/or provide acceptable palliation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21689621     DOI: 10.1016/j.cld.2011.03.013

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  7 in total

1.  Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis.

Authors:  Shushan Yan; Donghua Xu; Beicheng Sun
Journal:  Dig Dis Sci       Date:  2012-05-15       Impact factor: 3.199

2.  Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis.

Authors:  Shushan Yan; Donghua Xu; Beicheng Sun
Journal:  Dig Dis Sci       Date:  2013-01-30       Impact factor: 3.199

Review 3.  Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies.

Authors:  Thomas J Vogl; Parviz Farshid; Nagy N N Naguib; Abbas Darvishi; Babak Bazrafshan; Emmanuel Mbalisike; Thorsten Burkhard; Stephan Zangos
Journal:  Radiol Med       Date:  2014-06-04       Impact factor: 3.469

Review 4.  Liver transplantation: past, present and future.

Authors:  Ali Zarrinpar; Ronald W Busuttil
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-06-11       Impact factor: 46.802

Review 5.  Managing the changing burden of cancer in Asia.

Authors:  Rengaswamy Sankaranarayanan; Kunnambath Ramadas; You-lin Qiao
Journal:  BMC Med       Date:  2014-01-08       Impact factor: 8.775

6.  A synchronous hepatocellular carcinoma and renal cell carcinoma treated with radio-frequency ablation.

Authors:  Yoon Serk Lee; Jeong Han Kim; Hyeon Young Yoon; Won Hyeok Choe; So Young Kwon; Chang Hong Lee
Journal:  Clin Mol Hepatol       Date:  2014-09-25

7.  Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study.

Authors:  Chengwu Tang; Jian Shen; Wenming Feng; Ying Bao; Xiaogang Dong; Yi Dai; Yinyuan Zheng; Jianping Zhang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.